Zelira Therapeutics Ltd (ZLD)

Sydney
0.970
0.000(0.00%)
  • Volume:
    22,398
  • Bid/Ask:
    0.970/1.000
  • Day's Range:
    0.950 - 0.975

ZLD Overview

Prev. Close
0.97
Day's Range
0.95-0.975
Revenue
1.3M
Open
0.97
52 wk Range
0.018-8.925
EPS
-1.5
Volume
22,398
Market Cap
9.29M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
12,509
P/E Ratio
-
Beta
1.91
1-Year Change
-87.66%
Shares Outstanding
9,577,116
Next Earnings Date
-
What is your sentiment on Zelira Therapeutics?
or
Market is currently closed. Voting is open during market hours.

Zelira Therapeutics Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Zelira Therapeutics Ltd Company Profile

Zelira Therapeutics Ltd Company Profile

Employees
0
Market
Australia

Zelira Therapeutics Limited is an Australia-based cannabinoid-based biopharmaceutical company. It is focused on developing and clinically validating branded cannabinoid-based medicines for the treatment of a variety of medical conditions in its prescription (Rx) business, including insomnia, autism and chronic non-cancer pain. Its lead product, Zenivol, is a cannabinoid-based medicine for the treatment of chronic insomnia. It also provides formulations under the HOPE brand. The Company is engaged in human clinical trial programs focused on insomnia, autism and opioid reduction with activities in Australia and the United States. It is also focused on pre-clinical research examining the effects of cannabinoids in breast, brain and pancreatic cancer, as well as research and development of cannabinoids to treat diabetes-associated cognitive diseases. Its SprinjeneCBD toothpaste product is a hemp-derived, oral care product containing cannabinoids, based on the technology of blackseed oil.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuySellSellStrong SellStrong Sell
Technical IndicatorsStrong BuyBuyStrong SellStrong SellStrong Sell
SummaryStrong BuyNeutralStrong SellStrong SellStrong Sell